S&P Global Ratings believes that UnitedHealth’s overall strategy, focusing on diversified insurance and health care services growth, remains sound. However, the company underestimated the negative ...

US insurance behemoth UnitedHealth Group is suing The Guardian for defamation weeks after the British-based newspaper published a salacious investigative report alleging the company intentionally ...

Thousands of Maryland residents who buy health insurance from the state could see an 18% spike in their premiums in 2026.

UnitedHealth Group is suing The Guardian for defamation following the publication of an investigative report from the media outlet that accuses the company of engaging in harmful and fraudulent ...

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

UnitedHealthcare and Optum's struggles with an evolving Medicare Advantage market have investors questioning if valued-based ...

Due to the sharp price decline, the yield from the stock's dividend has climbed to 2.8%, which is higher than the S&P 500 ...

The health insurer has suffered mounting problems and backlash since the fatal shooting of former CEO Brian Thompson.

UnitedHealth Group's board has raised the healthcare giant's quarterly dividend by 5.2%, to $2.21 from $2.10. The new payout, equal to $8.84 a year, represents an annual yield of 2.93% based on ...

UnitedHealth Group Incorporated’s UNH new CEO, Steve Hemsley, began his return to leadership by issuing a rare apology to ...

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

UnitedHealth Group shares appear undervalued after 50% decline, and concerns about a potential DOJ investigation seem ...